NEW YORK, Dec. 19, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Skye Bioscience, Inc. ("Skye Bioscience, Inc." or the "Company") (NASDAQ: SKYE) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Skye Bioscience, Inc. investors who were adversely affected by alleged securities fraud between November 4, 2024 and October 3, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslr ...

Core Viewpoint - A class action securities lawsuit has been filed against Telix Pharmaceuticals Ltd. alleging securities fraud that affected investors between February 21, 2025, and August 28, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that defendants made false statements regarding Telix's progress with prostate cancer therapeutic candidates, overstated the quality of its supply chain and partners, and that these statements were materially false and misleading [2]. - Investors who suffered losses during the specified timeframe have until January 9, 2026, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. Group 2: Legal Representation - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders and being recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].

NEW YORK, Dec. 19, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Stride, Inc. ("Stride" or the "Company") (NYSE: LRN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Stride investors who were adversely affected by alleged securities fraud between October 22, 2024 and October 28, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/stride-inc-lawsuit-submission-form-3? ...

Core Viewpoint - A class action securities lawsuit has been filed against Inspire Medical Systems, Inc. due to alleged securities fraud affecting investors between August 6, 2024, and August 4, 2025 [1] Group 1: Lawsuit Details - The lawsuit claims that the launch of Inspire Medical's new product, Inspire V, was unsuccessful due to poor demand, as providers had excess inventory and were hesitant to adopt the new treatment [2] - Defendants allegedly made false statements regarding the successful launch of Inspire V, while failing to complete essential tasks such as training for treatment center customers and setting up necessary IT systems [2] - Critical issues included the lack of updates to insurer claims software and the absence of Medicare reimbursement at the time of the product launch [2] Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until January 5, 2026, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing significant settlements for shareholders and is recognized as one of the top securities litigation firms in the United States [4]

Core Viewpoint - A class action securities lawsuit has been filed against Primo Brands Corporation / Primo Water Corporation, alleging securities fraud that affected investors between June 17, 2024, and November 6, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that the defendants made false statements and concealed issues regarding the merger integration between Primo Water and BlueTriton Brands, which was reportedly tracking poorly due to technology and service problems [3]. - It is alleged that contrary to the defendants' assurances of a "flawless" execution, Primo Brands faced significant supply disruptions that negatively impacted customers and financial results [3]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until January 12, 2026, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [4]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, with no obligation to participate [4]. Group 3: Legal Representation - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the United States [5].

Core Viewpoint - A class action securities lawsuit has been filed against James Hardie Industries plc, alleging securities fraud that negatively impacted investors between May 20, 2025, and August 18, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that James Hardie made false statements and concealed adverse facts regarding its North America segment, including deteriorating consumer demand and growth being driven by overstocking rather than actual demand [2]. - Excessive inventory at James Hardie's North America distributors is highlighted as a significant issue resulting from the alleged misrepresentation of growth drivers [2]. Group 2: Investor Information - Investors who suffered losses during the specified period have until December 23, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving in this role [3]. - Class members may be entitled to compensation without incurring any out-of-pocket costs or fees, indicating a no-cost participation model [3]. Group 3: Legal Firm Background - Levi & Korsinsky, the firm representing the investors, has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4]. - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years, according to ISS Securities Class Action Services [4].

Core Points - A class action securities lawsuit has been filed against Avantor, Inc. for alleged securities fraud affecting investors between March 5, 2024, and October 28, 2025 [1][2] - The lawsuit claims that Avantor's competitive positioning was misrepresented, indicating that the company was facing negative impacts from increased competition [2] - Investors who suffered losses during the specified period have until December 29, 2025, to request to be appointed as lead plaintiff [3] Company Details - The complaint alleges that the defendants made false statements regarding Avantor's business operations and prospects, which were materially misleading [2] - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years [4]

Core Viewpoint - DeFi Technologies is facing a class action securities lawsuit due to alleged securities fraud that negatively impacted investors between May 12, 2025, and November 14, 2025 [1][2]. Group 1: Allegations and Impact - The lawsuit claims that DeFi Technologies made false statements regarding delays in executing its DeFi arbitrage strategy, which is a key revenue driver for the company [2]. - It is alleged that the company understated the competition it faced from other digital asset treasury companies, which adversely affected its ability to execute its DeFi arbitrage strategy [2]. - As a result of these issues, DeFi Technologies is unlikely to meet its previously issued revenue guidance for the fiscal year 2025 [2]. - The defendants are accused of downplaying the negative impact of these issues on the company's business and financial results, leading to materially false and misleading public statements [2]. Group 2: Legal Process and Participation - Investors who suffered losses in DeFi Technologies during the relevant time frame have until January 30, 2026, to request to be appointed as lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, and participation does not require serving as a lead plaintiff [3]. Group 3: Firm Background - Levi & Korsinsky has a strong track record, having secured hundreds of millions of dollars for shareholders and being recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].

Core Points - A class action securities lawsuit has been filed against Freeport-McMoRan Inc. for alleged securities fraud affecting investors between February 15, 2022, and September 24, 2025 [1][2] - The lawsuit claims that Freeport failed to ensure safety at the Grasberg Block Cave mine in Indonesia, leading to increased risks for workers and potential regulatory and reputational consequences [2] - Investors who suffered losses during the specified period have until January 12, 2026, to request to be appointed as lead plaintiff, with no costs required to participate in the lawsuit [3] Company Details - The complaint alleges that Freeport's statements regarding its business operations and prospects were materially false and misleading due to undisclosed safety risks [2] - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years [4]

Core Viewpoint - A class action lawsuit has been filed against CarMax, Inc. and certain senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][2]. Group 1: Lawsuit Details - Investors have until January 2, 2026, to request to lead the case, which is pending in the U.S. District Court for the District of Maryland [2]. - The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of CarMax investors [2]. Group 2: Company Performance and Stock Impact - CarMax reported disappointing financial results for Q2 FY 2026, including a 5.4% decline in retail used unit sales, a 6.3% decline in comparable store used unit sales, and a 2.2% decline in wholesale units [5]. - The company's net income for Q2 was approximately $95.4 million, down from $132.8 million the previous year, attributed to a "pull forward" in demand due to U.S. tariffs [5]. - Following the financial report, CarMax's stock price dropped by $11.45 per share, or roughly 20%, from $57.05 on September 24, 2025, to $45.60 on September 25, 2025 [6]. - An unexpected departure of CEO Bill Nash on November 6, 2025, along with a weak preliminary Q3 2025 outlook, led to an additional stock drop of over 24% [6]. Group 3: Company Background - CarMax is a leading retailer of used cars, emphasizing a seamless customer experience and strong demand for its vehicles [3]. - The law firm Bleichmar Fonti & Auld LLP, known for representing plaintiffs in securities class actions, is handling the lawsuit against CarMax [10].